Star Combo Pharma Ltd has released a press release.
Pause in Trading
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Star Combo Pharma
- Half Yearly Report and Accounts
- 2019 AGM Chairman and CEO Presentation
- Inature Organic Care acquisition
- S66 2019 Results Commentary
- Termination of the Bio-E Share Sale Agreement
Later from Star Combo Pharma
- Trading Halt
- S66 Agrees Private Placement to Goldenmax
- S66 ASX Appendix 3B
- Star Combo Completes $33.3m Placement at $0.68 per share
- Star Combo Acquisition of iNature Option not exercised
Follow Star Combo Pharma into a list and get an email when it puts out news.
Follow Star Combo Pharma